US 11021469
Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same
granted A61PA61P31/04
Quick answer
US patent 11021469 (Indoline sulfonamide inhibitors of DapE and NDM-1 and use of the same) held by The Board of Regents of the University of Texas System expires Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time). Status: granted.
Key facts
- Applicant
- The Board of Regents of the University of Texas System
- Grant date
- Tue Jun 01 2021 00:00:00 GMT+0000 (Coordinated Universal Time)
- Expiration
- Mon May 27 2041 00:00:00 GMT+0000 (Coordinated Universal Time)
- Claims
- 20
- CPC classes
- A61P, A61P31/04